Norcantharidin, an angiogenic inhibitor in gallbladder cancer, has been shown to inhibit cancer cell proliferation, migration, and invasion and to reduce angiogenesis based on decreased MVD and VEGF expression [7]. Here, VEGFA is linked to cancer.